Browse by author
Lookup NU author(s): Dr Dina Mansour
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Purpose: Despite considerable advances in recently developed combined oral contraceptives (COCs), resulting in lower rates of adverse events while maintaining contraceptive efficacy, there is interest in further innovation. Materials and Methods: Estetrol (E4), a native oestrogen, and progestin drospirenone (DRSP) were combined in a new COC. A European expert panel reviewed the pharmacology, efficacy, and safety and tolerability of this combination. Their findings are presented as a narrative review. Results: E4 15 mg/DRSP 3 mg in a 24/4 regimen provided effective contraception with good cycle control, characterised by a predictable regular bleeding pattern and minimal unscheduled bleeding, together with a good safety profile. The combination was associated with high user satisfaction, well-being, and minimal changes in body weight. The effects on endocrine and metabolic parameters were limited, and the combination was found to have a limited impact on liver function and lipid and carbohydrate metabolism. Moreover, its effect on several haemostatic parameters was lower than that of comparators containing ethinyl oestradiol (EE) 20 µg/DRSP 3 mg and EE 30 µg/levonorgestrel 150 µg. Conclusion: E4 15 mg/DRSP 3 mg provides safe and effective contraception, with high user satisfaction and predictable bleeding. Further research will evaluate the long-term safety of the COC.
Author(s): Gemzell-Danielsson K, Cagnacci A, Chabbert-Buffet N, Douxfils J, Foidart J-M, Kubba A, Lete Lasa LI, Mansour D, Neulen J, Neves J, Palma F, Romer T, Spaczynski R, Toth V
Publication type: Review
Publication status: Published
Journal: European Journal of Contraception and Reproductive Health Care
Year: 2022
Volume: 27
Issue: 5
Pages: 373-383
Online publication date: 21/07/2022
Acceptance date: 21/06/2022
ISSN (print): 1362-5187
ISSN (electronic): 1473-0782
Publisher: Taylor and Francis Ltd.
URL: https://doi.org/10.1080/13625187.2022.2093850
DOI: 10.1080/13625187.2022.2093850
